Salym Liufau was at a family birthday party in 2022 when she squatted to pick up her kids, a motion she’d done a million ...

Measuring the electrical activity of muscles in the neck in ALS may be easier for some patients than using the tongue for ...

Certain subsets of microglia were found to be enriched in nervous system tissues from people with amyotrophic lateral ...

Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor ...

A patient with amyotrophic lateral sclerosis (ALS) has become the first person in the world to control an iPad entirely by ...

Amyotrophic lateral sclerosis (ALS) is a neurological disorder which can reduce the life span of the affected individual. Supportive treatment helps to make the patient comfortable.

The amyotrophic lateral sclerosis (ALS) treatment market was valued at USD 791.90 Million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 5.40% from 2025 to 2034.

Future risk of amyotrophic lateral sclerosis (ALS) is found to be lower when associated with certain blood lipid biomarkers linked to cardiovascular disease risk as per a study published online in ...

Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Annals of Neurology, 2011; 69 (1): 141 DOI: 10.1002/ana.22149 ...

DUBLIN, June 18, 2019 /PRNewswire/ -- The "Market Spotlight: Amyotrophic Lateral Sclerosis (ALS)" report has been added to ResearchAndMarkets.com's offering.